Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review - Aarkstore Enterprise

Aarkstore announce a new report "Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review " through its vast collection of market research report.

Nuvo Research Inc. (Nuvo Research) is a publicly held pharmaceutical company. It is engaged in the research and development(R&D) of pharmaceutical products related to skin diseases. The company functions through two business areas namely topical and transdermal drug delivery. Additionally, the company conducts research on immune system regulation. The company's product portfolio comprises of pennsaid which is used to treat the pain and symptoms and oxoferin which is used for topical wound healing.

Nuvo Research Inc. Key Recent Developments

Apr 29, 2010: Nuvo Research Reports Net Loss Of CAD3 Million For Q1 2010
Nov 11, 2009: Nuvo Research Enters Into Licensing Agreement With Ranbaxy
Nov 05, 2009: FDA Approves NDA For Pennsaid Topical Solution
Aug 04, 2009: FDA Extends Review Of Pennsaid Diclofenac Sodium Topical Solution
Jun 16, 2009: Nuvo, Covidien Sign Development Agreement

This comprehensive SWOT profile of Nuvo Research Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nuvo Research Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:
http://www.aarkstore.com/reports/Nuvo-Research-Inc-NRI-Financial-and-Strategic-Analysis-Review-49557.html
Or email us at press@aarkstore.com or call +919272852585

Was this helpful? 0 0 Comments

You're reading Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review - Aarkstore Enterprise.